New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment
Por um escritor misterioso
Descrição
In a recent article published in Clinical Microbiology and Infection, researchers reviewed all registered trials currently investigating potential treatment options for post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS).
Long COVID and its Management
COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration ― United States, May 11, 2023
Researchers Race to Understand Long COVID in National Study, The Brink
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study - The Lancet Respiratory Medicine
CDC Museum COVID-19 Timeline, David J. Sencer CDC Museum
Full article: Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research
Understanding the Post COVID-19 Condition (Long COVID) in Adults and the Expected Burden for Ontario - Ontario COVID-19 Science Advisory Table
Long COVID: pathophysiological factors and abnormalities of coagulation: Trends in Endocrinology & Metabolism
New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment
IJERPH, Free Full-Text
Frontiers Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID- 19
Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial - eClinicalMedicine
A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine
Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study
Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study
de
por adulto (o preço varia de acordo com o tamanho do grupo)
